Moderna ($MRNA) stock surged 130% following reports that a cancer vaccine showed signs of preventing melanoma from spreading.
Moderna $MRNA surges 130%
Moderna
Brand Topic Feed 2 following
Moderna is an American biotechnology company headquartered in Cambridge, Massachusetts, focused on messenger RNA (mRNA) therapeutics and vaccines.
60 posts 0 videos 2 following
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
Moderna skin cancer vaccine results
Moderna's mRNA flu vaccine just got a big boost. An independent FDA advisory panel unanimously recommended it for approval in older adults. The vaccine showed about 27% better efficacy than standard flu shots in clinical…
Moderna mRNA flu vaccine FDA panel
